FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

21 letters match. Newest first.

  1. Shoplet

    FDA warned Shoplet over website sales of unapproved, misbranded triclosan antiseptic lotion soaps.

    Medium
  2. Save Rite Medical

    Save Rite Medical sold triclosan antiseptic lotion soaps online as unapproved, misbranded new drugs.

    Medium
  3. Medical Mega

    FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.

    Medium
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk
  5. Yahon Enterprise Co., Ltd.

    FDA warned Yahon Enterprise over manufacturing quality failures for OTC antiseptic wipes after a December 2023 inspection.

    High risk
  6. Betone S.A. de C.V.

    FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.

    High risk
  7. Midlab Incorporated

    FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.

    High risk
  8. Gascó Industrial Corporation

    FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.

    High risk
  9. CofixRx, LLC

    FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.

    High risk
  10. Agropharma Laboratories, Inc.

    FDA cited Agropharma Laboratories in Salinas, Puerto Rico, for serious manufacturing violations affecting its OTC antiseptics and hand sanitizers.

    High risk
  11. Viraldine, LLC

    Viraldine sold unapproved povidone-iodine nasal and throat sprays claiming to prevent or treat COVID-19.

    High risk
  12. Professional Disposables International, Inc.

    Professional Disposables International, a New York drug manufacturer, failed to properly investigate out-of-specification test results for Prevantics antiseptic swabs and Povidone-Iodine products.

    High risk
  13. Spartan Chemical Company, Inc.

    FDA found B. cepacia contamination and CGMP failures at Spartan Chemical’s hand sanitizer plant, plus unapproved COVID-19 claims.

    High risk
  14. DongBang Cosmetics Co., Ltd.

    DongBang Cosmetics of Incheon shipped a hand sanitizer labeled 62% alcohol that tested at 55%, and it was refused at the U.S. border.

    High risk
  15. Blue Willow Biologics

    FDA warned Blue Willow Biologics over its NanoBio Protect nasal antiseptic sold with unapproved COVID-19 prevention and treatment claims.

    High risk
  16. Halodine, LLC

    Halodine, LLC marketed unapproved nasal and oral antiseptic drugs with COVID-19 prevention and treatment claims, FDA says.

    High risk
  17. Biotek India

    Biotek India, an OTC drug maker, lacked active-ingredient testing and sold an unapproved 99% isopropyl rubbing alcohol.

    High risk
  18. BGP, LLC

    FDA and FTC warned BGP, LLC that its Biocence topical antiseptic is an unapproved, misbranded drug sold with COVID-19 treatment and prevention claims.

    High risk
  19. Disinfect & Shield

    FDA warned Disinfect & Shield that its non-alcohol hand sanitizer was an unapproved drug sold with COVID-19 and long-lasting efficacy claims.

    High risk
  20. Hou Fu Biotech - Jiangsu Co., Ltd

    Hou Fu Biotech shipped PANROSA hand sanitizer labeled 70% ethanol but tested at 45%, adulterated and misbranded.

    High risk
  21. Gaza Proveedora De Servicios De Hospedaje Y Alimentacion

    Gaza Proveedora's Pristine Hand Sanitizer Gel, labeled 68% ethanol, tested at 42% and was refused U.S. admission.

    High risk